ACHV insider trading
NasdaqCM HealthcareACHIEVE LIFE SCIENCES, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Company website: www.achievelifesciences.com
ACHV insider activity at a glance
FilingIQ has scored 149 insider transactions for ACHV since Aug 1, 2017. The most recent filing in our index is dated May 11, 2026.
Across the full history, 10 open-market purchases
and 38 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ACHV insider trades is 59.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ACHV Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ACHV?
- FilingIQ tracks 149 Form 4 insider transactions for ACHV (ACHIEVE LIFE SCIENCES, INC.), covering filings from Aug 1, 2017 onwards. 4 of those were filed in the last 90 days.
- Are ACHV insiders net buyers or net sellers?
- Across the full Form 4 history for ACHV, 10 transactions (7%) were open-market purchases and 38 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ACHV insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ACHV in?
- ACHIEVE LIFE SCIENCES, INC. (ACHV) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $229.97M.
Methodology & sources
Every ACHV insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.